Skinergy Dermatology | January/February 2015
UH Night

Key milestones reached in NIH/FDA-
sponsored clinical trial for cutaneous T cell lymphoma

A new therapeutic option for patients with cutaneous T-cell lymphoma, mycosis fungoides type is being tested at University Hospitals Cleveland Medical Center (UHCMC) and Case Western Reserve University (CWRU). The trial involves a photodynamic skin directed therapy involving red light and a topical photosensitizer which target activated and malignant T-cells.

READ MORE >>

Unexplained Multiple Melanomas affecting siblings generates research for new causes of melanomas in adolescents and young adults.

A set of young siblings who have each developed at least eight different primary melanomas but who have unaffected parents, stimulated a new research program to help find the underlying problem leading to all these potentially very risky cancers.

READ MORE >>

CWRU Scientists Identify Proteins Likely to Trigger Psoriasis

Dr. Nicole Ward and her team of scientists are focusing on understanding and uncovering the role and significance of proteins in the progression of psoriasis. Determining the individual contributions of each protein will help provide strategic therapeutic targets to change the course of a patient’s psoriasis or, at the very least, provide a better understanding of how a change in the regulation of these proteins contributes to skin inflammation and psoriatic disease.

READ MORE >>

Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation

Dr. Neil Korman, Professor of Dermatology at University Hospitals Cleveland Medical Center is conducting a study to determine cardiovascular risk in patients 18-65 years old.

READ MORE >>

Department Faculty, Residents and Fellows to share new research findings at the Society for Investigative Dermatology annual meeting

Read highlights on new research on psoriasis, sleep-skin disturbances, melanoma, chemical weapon effects on skin and blood, nervous system effects on skin, and relationship of atherosclerosis and psoriasis

READ MORE >>


New funding, New Name for NIH-Sponsored Training of Dermatology and Skin Biology Researchers

After national peer review, the Department’s application to the NIH National Institute for Arthritis, Musculoskeletal and Skin Disease received a priority score within the Institute’s payline. The name was changed to reflect its strengths and is now titled “The Case Investigative and Translational Dermatology Training Program”.

READ MORE >>

Division of Mohs Micrographic and Dermatologic Surgery Launches New Fellowship

Division Director Dr. Jeremy Bordeaux, working with Drs. Margaret Mann and Jennifer Bahner, received approval to begin a new Moh’s Micrographic Surgery Fellowship.. Chief Academic Resident Dr. Jennifer DePry will be the inaugural fellow.

READ MORE >>

Viewed by website counter